Preparing for the Post-Brexit Clinical Supply Chain
Pharma Industry, Regulatory
For clinical trial sponsors and clinical supply vendors with research in the United Kingdom (UK) and/or the European Union (EU), changes are coming. With the UK scheduled to leave the EU on March 29, 2019, understanding how this will affect the clinical supply chain is critical to supporting ongoing research. While political negotiations are ongoing, and the exact outcome is unclear, the research industry needs to prepare now.
Related Education Resources.
All ResourcesCurrent Challenges in Cell and Gene Therapy
Topic: Regulatory
Webinar
Free
Video on eTMF Requirements provided by Steve Jacobs, Chairman at Global BioPharm Solutions.
Topics: Pharma Industry, Strategic Planning
Video
Members
Requirements of a QP
Topic: Pharma Industry
Video
Members